Search research articles
Contact Us
Filters
Showing results (651-660 of 829) with videos related to
Page
of 83
Sort By:
Journal of Neuropathology and Experimental Neurology
|
December 1, 2021
Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation
Katherine T Lind, Hannah V Chatwin, John DeSisto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 26, 2009
A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium
Natasha B Leighl, Scott A Laurie, Xueyu E Chen, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
British Journal of Cancer
|
May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
S J Knox, M L Goris, K Trisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer
S J Knox, M L Goris, M Tempero, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2019
Discovery of new indole-based acylsulfonamide Na<sub>v</sub>1.7 inhibitors
Yong-Jin Wu, Brian Venables, Jason Guernon, et al.
NPJ Precision Oncology
|
March 24, 2023
Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data
Travis Zack, Kurt P Losert, Samantha M Maisel, et al.
Cancer Medicine
|
June 13, 2020
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database
Mohammed A Alghamdi, Carla P Amaro, Richard Lee-Ying, et al.
The Journal of Organic Chemistry
|
April 28, 2026
α,β-Dehydroamino-Acid-Containing Peptides Resist Proteolysis and Inhibit Aggregation of a Tau-Derived Model Peptide
Stephanie G Garcia, Ahmad Abdullatif Almardini, Aramis J Pereira, et al.
Page
of 83
Search research articles
Search
Showing results (651-660 of 829) with videos related to
Sort By:
Page
of 83
Journal of Neuropathology and Experimental Neurology
|
December 1, 2021
Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation
Katherine T Lind, Hannah V Chatwin, John DeSisto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 26, 2009
A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium
Natasha B Leighl, Scott A Laurie, Xueyu E Chen, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
British Journal of Cancer
|
May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
S J Knox, M L Goris, K Trisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer
S J Knox, M L Goris, M Tempero, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2019
Discovery of new indole-based acylsulfonamide Na<sub>v</sub>1.7 inhibitors
Yong-Jin Wu, Brian Venables, Jason Guernon, et al.
NPJ Precision Oncology
|
March 24, 2023
Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data
Travis Zack, Kurt P Losert, Samantha M Maisel, et al.
Cancer Medicine
|
June 13, 2020
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database
Mohammed A Alghamdi, Carla P Amaro, Richard Lee-Ying, et al.
The Journal of Organic Chemistry
|
April 28, 2026
α,β-Dehydroamino-Acid-Containing Peptides Resist Proteolysis and Inhibit Aggregation of a Tau-Derived Model Peptide
Stephanie G Garcia, Ahmad Abdullatif Almardini, Aramis J Pereira, et al.
Page
of 83